Grant: Discovery Grants Program - Individual
Université du Québec à Montréal
$18,000.00
Methodology and design for biostatistics
EF 2012-13
Résumé
My research agenda concerns the areas of optimal and experimental design and survival analysis. In optimal design one determines where or when measurements should be taken in order to make the ""best"" inference possible from the data that will be collected. For the purpose of illustration, consider a clinical trial where 50 people are administered a blood pressure lowering treatment. Can we develop designs that will allow us to ""best"" estimate: (i) the proportion of people affected by the treatment, (ii) the timing of the treatment effect and/or, (iii) the before- and after-change average blood pressures. An interesting application of experimental design is in genomics. In the last 20 years many new technologies have been developed for studying our DNA and variations in our DNA that might suggest predisposition to diseases such as cancer. These experiments are often very costly hence their design is a key issue in ensuring that the best quality data possible can be collected.
The area of survival analysis is concerned with observations of ""lifetimes"" that are incomplete in some way. For example, when following subjects from the onset of their disease some may be lost to follow-up. All that is known for such subjects is that they survived up until they were lost from the study. My proposed research in survival analysis is concerned with observed ""lifetimes"" that tend to be longer than expected because of the way the subjects were selected into the study group. Simply, longer survivors are observed, shorter ones are not, and adjustments in the analysis must be made to accommodate this selection bias. These adjustments help improve our inference and, hence, they have important implications when considering the natural history of a disease.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
356107-2009
Name nom
Atherton, Juli
Department département
Mathématiques
Organization id
57
Institution établissement
Université du Québec à Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2009
Award amount
18000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
14
Committee name en
Statistical Sciences
Committee name fr
Statistique
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3005
Research subject group en
Statistics and probability
Research subject group fr
Statistique et probabilité
Research subject en
Biostatistics
Research subject fr
Biostatistiques
Partie
4
Nb partie
5
Application title
Methodology and design for biostatistics
Keyword
NSERC
Application summary
My research agenda concerns the areas of optimal and experimental design and survival analysis. In optimal design one determines where or when measurements should be taken in order to make the ""best"" inference possible from the data that will be collected. For the purpose of illustration, consider a clinical trial where 50 people are administered a blood pressure lowering treatment. Can we develop designs that will allow us to ""best"" estimate: (i) the proportion of people affected by the treatment, (ii) the timing of the treatment effect and/or, (iii) the before- and after-change average blood pressures. An interesting application of experimental design is in genomics. In the last 20 years many new technologies have been developed for studying our DNA and variations in our DNA that might suggest predisposition to diseases such as cancer. These experiments are often very costly hence their design is a key issue in ensuring that the best quality data possible can be collected.
The area of survival analysis is concerned with observations of ""lifetimes"" that are incomplete in some way. For example, when following subjects from the onset of their disease some may be lost to follow-up. All that is known for such subjects is that they survived up until they were lost from the study. My proposed research in survival analysis is concerned with observed ""lifetimes"" that tend to be longer than expected because of the way the subjects were selected into the study group. Simply, longer survivors are observed, shorter ones are not, and adjustments in the analysis must be made to accommodate this selection bias. These adjustments help improve our inference and, hence, they have important implications when considering the natural history of a disease.